69192-0001 NDC - NEXGEN RESTORE (ASCLEPIAS VINCETOXICUM, ECHINACEA (ANGUSTIFOLIA), HYPOTHALAMUS (SUIS), BRAIN (SUIS), HEPAR SUIS, KIDNEY (SUIS), METHYLCOBALAMIN, PANCREAS SUIS, STOMACH (SUIS), AACG-A, AACG-B, CALCAREA CARBONICA, GAMBOGIA, GELSEMIUM SEMPERVIRENS, GRAPHITES, NUX VOMICA, PHYTOLACCA DECANDRA, 7-KETO DHEA (DEHYDROEPIANDROSTERONE), ADENOSINUM TRIPHOSPHORICUM DINATRUM, GLUCAGON, INSULINUM, SARCOLACTICUM ACIDUM, PROTEUS (VULGARIS))

Drug Information

  • Product NDC: 69192-0001
  • Proprietary Name: Nexgen Restore
  • Non Proprietary Name: Asclepias Vincetoxicum, Echinacea (Angustifolia), Hypothalamus (Suis), Brain (Suis), Hepar Suis, Kidney (Suis), Methylcobalamin, Pancreas Suis, Stomach (Suis), Aacg-A, Aacg-B, Calcarea Carbonica, Gambogia, Gelsemium Sempervirens, Graphites, Nux Vomica, Phytolacca Decandra, 7-Keto Dhea (Dehydroepiandrosterone), Adenosinum Triphosphoricum Dinatrum, Glucagon, Insulinum, Sarcolacticum Acidum, Proteus (Vulgaris)
  • Active Ingredient(s): 30 [hp_X]/mL 7-KETO-DEHYDROEPIANDROSTERONE; 30 [hp_X]/mL ADENOSINE TRIPHOSPHATE DISODIUM; 8 [hp_X]/mL APC-356433; 8 [hp_X]/mL APC-356434; 6 [hp_X]/mL CYNANCHUM VINCETOXICUM ROOT; 6 [hp_X]/mL ECHINACEA ANGUSTIFOLIA; 12 [hp_X]/mL GAMBOGE; 12 [hp_X]/mL GELSEMIUM SEMPERVIRENS ROOT; 30 [hp_X]/mL GLUCAGON; 12 [hp_X]/mL GRAPHITE; 30 [hp_X]/mL INSULIN PORK; 30 [hp_X]/mL LACTIC ACID, L-; 8 [hp_X]/mL METHYLCOBALAMIN; 12 [hp_X]/mL OYSTER SHELL CALCIUM CARBONATE, CRUDE; 12 [hp_X]/mL PHYTOLACCA AMERICANA ROOT; 8 [hp_X]/mL PORK BRAIN; 8 [hp_X]/mL PORK KIDNEY; 8 [hp_X]/mL PORK LIVER; 30 [hp_C]/mL PROTEUS VULGARIS; 12 [hp_X]/mL STRYCHNOS NUX-VOMICA SEED; 6 [hp_X]/mL SUS SCROFA HYPOTHALAMUS; 8 [hp_X]/mL SUS SCROFA PANCREAS; 8 [hp_X]/mL SUS SCROFA STOMACH
  • Administration Route(s): ORAL
  • Dosage Form(s): LIQUID
  • Pharmacy Class(es): Allergens [CS]; Antihypoglycemic Agent [EPC]; Cell-mediated Immunity [PE]; Decreased GI Motility [PE]; Decreased GI Smooth Muscle Tone [PE]; Decreased Glycolysis [PE]; Gastrointestinal Motility Inhibitor [EPC]; Increased Gluconeogenesis [PE]; Increased Glycogenolysis [PE]; Increased Histamine Release [PE]; Increased IgG Production [PE]; Non-Standardized Plant Allergenic Extract [EPC]; Plant Proteins [CS]; Seed Storage Proteins [CS]

Labeler Information

Field Name Field Value
Labeler Name: Next Generation Health
Product Type: HUMAN OTC DRUG
FDA Application Number:
Marketing Category: UNAPPROVED HOMEOPATHIC
Start Marketing Date:8/18/2014
End Marketing Date:10/1/2025

Package Information

No. Package Code Package Description Billing Unit
169192-0001-130 mL in 1 BOTTLE, DROPPER (69192-0001-1)

NDC Record

Field Name Field Value Definition
PRODUCT NDC69192-0001The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
PRODUCT TYPE NAMEHUMAN OTC DRUGIndicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.
PROPRIETARY NAMENexgen RestoreThe proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
NON PROPRIETARY NAMEAsclepias Vincetoxicum, Echinacea (Angustifolia), Hypothalamus (Suis), Brain (Suis), Hepar Suis, Kidney (Suis), Methylcobalamin, Pancreas Suis, Stomach (Suis), Aacg-A, Aacg-B, Calcarea Carbonica, Gambogia, Gelsemium Sempervirens, Graphites, Nux Vomica, Phytolacca Decandra, 7-Keto Dhea (Dehydroepiandrosterone), Adenosinum Triphosphoricum Dinatrum, Glucagon, Insulinum, Sarcolacticum Acidum, Proteus (Vulgaris)The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
DOSAGE FORM NAMELIQUIDThe translation of the dosage form Code submitted by the firm.
ROUTE NAMEORALThe translation of the route code submitted by the firm, indicating route of administration.
START MARKETING DATE8/18/2014This is the date that the labeler indicates was the start of its marketing of the drug product.
END MARKETING DATE10/1/2025This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
MARKETING CATEGORY NAMEUNAPPROVED HOMEOPATHICProduct types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
LABELER NAMENext Generation HealthName of Company corresponding to the labeler code segment of the Product NDC.
SUBSTANCE NAME7-KETO-DEHYDROEPIANDROSTERONE; ADENOSINE TRIPHOSPHATE DISODIUM; APC-356433; APC-356434; CYNANCHUM VINCETOXICUM ROOT; ECHINACEA ANGUSTIFOLIA; GAMBOGE; GELSEMIUM SEMPERVIRENS ROOT; GLUCAGON; GRAPHITE; INSULIN PORK; LACTIC ACID, L-; METHYLCOBALAMIN; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PHYTOLACCA AMERICANA ROOT; PORK BRAIN; PORK KIDNEY; PORK LIVER; PROTEUS VULGARIS; STRYCHNOS NUX-VOMICA SEED; SUS SCROFA HYPOTHALAMUS; SUS SCROFA PANCREAS; SUS SCROFA STOMACHAn active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.
ACTIVE NUMERATOR STRENGTH30; 30; 8; 8; 6; 6; 12; 12; 30; 12; 30; 30; 8; 12; 12; 8; 8; 8; 30; 12; 6; 8; 8 
ACTIVE INGRED UNIT[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL 
PHARM CLASSESAllergens [CS], Antihypoglycemic Agent [EPC], Cell-mediated Immunity [PE], Decreased GI Motility [PE], Decreased GI Smooth Muscle Tone [PE], Decreased Glycolysis [PE], Gastrointestinal Motility Inhibitor [EPC], Increased Gluconeogenesis [PE], Increased Glycogenolysis [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS] 

Download Record

Download this NDC record record in Text format: Export

Download this NDC record record in Excel (CSV) format: Export

Download this NDC record record in XML format: Export

This page was last updated on: 6/6/2025

Previous Code
Next Code